22nd Mar 2021 11:40
Arix Bioscience PLC - focused on investing in biotech companies - Kicks off GBP25 million share buyback programme, which will run no later than December 22. Says all shares bought back will be put into treasury.
Additionally notes portfolio company Aura Biosciences' closing of an oversubscribed USD80 million financing, "following strong interest from leading global investors". Arix retains a 5.6% ownership stake in Aura following the financing, and no longer retains a seat on Aura's board.
Current stock price: 196.00 pence; up 4.5% on Monday
Year-to-date change: down 11%
By Greg Roxburgh; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
ARIX.L